Job title: Scientific Manager, Translational Immunology
Hans Brightbill earned an undergraduate degree from the University of California, Irvine, a PhD degree in Microbiology and Immunology from UCLA, and conducted postdoctoral studies in Immunology at the University of California, Berkeley. Dr. Brightbill joined Genentech in 2006. After a number of years in Immunology Discovery Research developing large and small molecule therapeutics for inflammatory and autoimmune disease targets, Hans recently joined the department of Translational Immunology at Genentech, where his lab focusses on preclinical disease model and therapeutic development in fibrotic diseases.
Panel Discussion: The Future of Modeling & High Throughput Drug Screening 10:00 am
day: Day Two